HEAD
KnowtheoperationofM.S.Excel,SPSS,RandMINITAB®, DoE(DesignofExperiment)
Knowthevariousstatisticaltechniquestosolvestatisticalproblems
Appreciatestatisticaltechniquesinsolvingtheproblems.
=a+by,Multipleregression,standarderrorofregression– PharmaceuticalExamplesProbability:Definition of probability, Binomial distribution, Normal distribution,Poisson’sdistribution,properties -problems Sample,Population,largesample,smallsample, Nullhypothesis,alternativehypothesis,sampling, essence of sampling, types of sampling, Error-I type,Error-II type, Standarderrorofmean(SEM)-Pharmaceutical examples Parametric test: t-test(Sample, Pooled or Unpaired and Paired) , ANOVA, (One wayandTwoway),Least Significancedifference
Blockingandconfoundingsystem forTwo-level factorials
Regression modeling: Hypothesis testing in Simple and Multiple regressionmodelsIntroductiontoPracticalcomponentsofIndustrialandClinicalTrialsPr oblems:StatisticalAnalysisUsingExcel,SPSS,MINITAB®,DESIGNOFEXPERIMENTS,R- OnlineStatisticalSoftware’stoIndustrialandClinical trialapproach
Factorial Design: Definition, 22, 23design. Advantage of factorial designResponseSurfacemethodology:Centralcompositedesign,Historicaldesign, OptimizationTechniques
Pharmaceuticalstatistics- Practicalandclinicalapplications,SanfordBolton,publisherMarcel DekkerInc.NewYork.
FundamentalofStatistics –HimalayaPublishingHouse-S.C.Guptha
DesignandAnalysisofExperiments–PHI LearningPrivateLimited,
R.Pannerselvam,
Design and AnalysisofExperiments– WileyStudentsEdition,DouglasandC.Montgomery
BP802TSOCIALAND PREVENTIVEPHARMACY (Theory)
The purpose of this course is to introduce to students a number of health issues and theirchallenges. This course also introduced a number of national health programmes. Therolesofthe pharmacistinthesecontextsarealso discussed.
Afterthesuccessfulcompletionofthiscourse,thestudentshallbeableto:
Acquirehighconsciousness/realizationofcurrentissuesrelatedtohealthandpharmace uticalproblemswithinthe countryandworldwide.
Have a critical wayofthinkingbasedon current healthcaredevelopment.
Evaluate alternative ways of solving problems related tohealth andpharmaceuticalissues
programme for prevention and control of deafness, Universal immunization programme,Nationalprogrammeforcontrolofblindness,Pulsepolioprogramme.
National health intervention programme for mother and child, National family welfareprogramme, National tobacco control programme, National Malaria Prevention Program,National programme for the health care for the elderly, Social health programme; role ofWHOinIndian nationalprogram
Community services in rural, urban and school health: Functions of PHC,Improvementin rural sanitation, national urban health mission, Health promotion and education inschool.
Short Textbook of Preventive and Social Medicine, Prabhakara GN, 2nd Edition,2010,ISBN: 9789380704104, JAYPEEPublications
Textbook of Preventive and Social Medicine (Mahajan and Gupta), Edited by RoyRabindra Nath, Saha Indranil, 4thEdition, 2013, ISBN: 9789350901878, JAYPEEPublications
Review of Preventive and Social Medicine (Including Biostatistics), Jain Vivek, 6thEdition,2014,ISBN: 9789351522331, JAYPEEPublications
EssentialsofCommunity Medicine—
APracticalApproach,HiremathLalitaD,HiremathDhananjayaA,2ndEdition,2012,ISBN
:9789350250440,JAYPEEPublications
ParkTextbook ofPreventiveandSocialMedicine,KPark,21stEdition,2011,ISBN- 14:9788190128285,BANARSIDASBHANOTPUBLISHERS.
CommunityPharmacyPractice,RameshAdepu,BSPpublishers, Hyderabad
ResearchinSocialandAdministrativePharmacy,Elsevier,Ireland
The pharmaceutical industry not only needs highly qualified researchers, chemists and,technicalpeople, butalsorequires skilled managers who cantake the industry forwardby managing and taking the complex decisions which are imperative for the growth of theindustry. The KnowledgeandKnow-how ofmarketing managementgroomthe peoplefortakingachallenging rolein Sales and Productmanagement.
Definition, general concepts and scope of marketing; Distinction between marketing &selling; Marketing environment; Industry and competitive analysis; Analyzing consumerbuyingbehavior; industrial buyingbehavior.
Quantitative and qualitative aspects; size and composition of the market; demographicdescriptionsandsocio- psychologicalcharacteristicsoftheconsumer;marketsegmentation&targeting.Consumerprofi le;Motivationandprescribinghabitsofthephysician;patients' choice of physicianand retailpharmacist.Analyzing the Market;Roleofmarket research.
Classification, product line and product mix decisions, product lifecycle,productportfolioanalysis;productpositioning;New productdecisions;Productbranding,packagingandlabelingdecisions,Productmanagementinp harmaceuticalindustry.
Methods,determinantsofpromotionalmix,promotionalbudget;Anoverviewofpersonalselling
,advertising,directmail,journals,sampling,retailing, medicalexhibition,publicrelations,onlinepromotionaltechniques forOTCProducts.
160
Meaning, importance, objectives, determinants of price; pricing methods and strategies,issuesinpricemanagementinpharmaceuticalindustry.AnoverviewofDPCO(DrugP riceControlOrder)andNPPA(NationalPharmaceuticalPricingAuthority).
Vertical & Horizontal Marketing; RuralMarketing; Consumerism; Industrial Marketing;GlobalMarketing.
PhilipKotlerandKevinLaneKeller:MarketingManagement,PrenticeHallofIndia,NewDel hi
Walker,BoydandLarreche:MarketingStrategy-PlanningandImplementation,TataMC GrawHill,NewDelhi.
DhruvGrewalandMichaelLevy:Marketing,TataMCGrawHill
ArunKumarandNMenakshi:MarketingManagement,VikasPublishing,India
RajanSaxena:MarketingManagement; TataMC Graw-Hill(IndiaEdition)
Ramaswamy,U.S&Nanakamari,S:MarketingManagemnt:GlobalPerspective,IndianCon text,MacmilanIndia,NewDelhi.
Shanker,Ravi:ServiceMarketing,ExcellBooks,NewDelhi
SubbaRaoChanganti,PharmaceuticalMarketinginIndia(GIFT– Excelseries)ExcelPublications.
161
Know about the processof drugdiscoveryanddevelopment
Knowtheregulatoryauthoritiesandagenciesgoverningthemanufactureandsaleofpha rmaceuticals
KnowtheregulatoryapprovalprocessandtheirregistrationinIndianandintern ationalmarkets
Stages of drug discovery, Drug development process, pre-clinical studies, non- clinicalactivities, clinical studies,Innovator andgenerics, Concept of generics, Generic drugproductdevelopment.
Approvalprocessesandtimelines involved inInvestigationalNew Drug (IND),NewDrug Application (NDA), Abbreviated New Drug Application (ANDA). Changes to anapprovedNDA/ ANDA.
Overview of regulatory authorities of India, United States, European Union,Australia,Japan,Canada(Organizationstructureand typesofapplications)
Procedure for export of pharmaceutical products, Technical documentation, Drug MasterFiles(DMF),CommonTechnicalDocument(CTD),electronicCommonTechnical
162
Document(eCTD),ASEANCommonTechnicalDocument(ACTD)research.
Developingclinicaltrialprotocols,InstitutionalReviewBoard/IndependentEthicscommittee- formationandworkingprocedures,Informedconsentprocessandprocedures,GCPobligationso fInvestigators,sponsors&Monitors,Managing andMonitoringclinical trials,Pharmacovigilance-safetymonitoringinclinical trials
Basicterminology,guidance,guidelines,regulations,LawsandActs,Orangebook,FederalReg ister,CodeofFederalRegulatory, Purplebook
DrugRegulatoryAffairsbySachinItkar,Dr.N.S.Vyawahare,Nirali Prakashan.
The Pharmaceutical Regulatory Process, Second Edition Edited by Ira R. Berry andRobertP. Martin, Drugs and the Pharmaceutical Sciences,Vol.185. Informa HealthcarePublishers.
NewDrugApprovalProcess:AcceleratingGlobalRegistrationsByRichardAGuar ino,MD,5thedition,DrugsandthePharmaceuticalSciences,Vol.190.
Guidebookfordrugregulatorysubmissions/SandyWeinberg.ByJohnWiley&Sons.I nc.
FDARegulatoryAffairs:aguideforprescriptiondrugs,medicaldevices,andbiolo gics/edited byDouglas J. Pisano,David Mantus.
GenericDrugProductDevelopment,SolidOralDosageforms,LeonShargelandIsader Kaufer,Marcel Dekkerseries,Vol.143
ClinicalTrialsandHumanResearch:APracticalGuidetoRegulatoryComplianceByFay A.RozovskyandRodneyK.Adams
PrinciplesandPracticesof ClinicalResearch, SecondEditionEditedby JohnI.GallinandFrederick P.Ognibene
Drugs:FromDiscoveryto Approval,SecondEditionByRickNg
163
At completion of this paper it is expected that students will be able to (know, do, andappreciate):
Whydrugsafetymonitoringisimportant?
Historyanddevelopmentofpharmacovigilance
Nationalandinternationalscenarioofpharmacovigilance
Dictionaries,codingandterminologiesusedinpharmacovigilance
Detectionofnewadversedrugreactionsandtheirassessment
Internationalstandardsforclassificationofdiseasesanddrugs
Adversedrugreactionreportingsystemsandcommunicationinpharmacovigilance
Methodstogeneratesafetydataduringpreclinical,clinicalandpostapprovalphasesofdrugs’ life cycle
Drugsafetyevaluationinpaediatrics,geriatrics,pregnancyandlactation
PharmacovigilanceProgramofIndia(PvPI)requirement for ADRreportinginIndia
ICHguidelinesforICSR,PSUR,expeditedreporting,pharmacovigilanceplanning
CIOMSrequirementsforADRreporting
Writingcasenarrativesofadverseeventsandtheirquality.
HistoryanddevelopmentofPharmacovigilance
ImportanceofsafetymonitoringofMedicine
WHOinternationaldrugmonitoringprogramme
PharmacovigilanceProgramofIndia(PvPI)
DefinitionsandclassificationofADRs
Detectionandreporting
MethodsinCausalityassessment
Severityandseriousnessassessment
Predictabilityandpreventabilityassessment
Managementofadversedrugreactions
164
Terminologiesofadversemedicationrelatedevents
Regulatoryterminologies
Anatomical,therapeuticandchemicalclassificationofdrugs
Internationalclassificationofdiseases
Dailydefineddoses
InternationalNonproprietaryNamesfordrugs
WHOadversereactionterminologies
MedDRAandStandardisedMedDRAqueries
WHOdrugdictionary
Eudravigilancemedicinalproductdictionary
Basicdruginformationresources
SpecialisedresourcesforADRs
Establishinginahospital
Establishment &operationofdrugsafetydepartment inindustry
ContractResearchOrganisations(CROs)
Establishinganationalprogramme
VaccinePharmacovigilance
Vaccinationfailure
Adverseeventsfollowingimmunization
Passivesurveillance–Spontaneousreportsandcaseseries
Stimulatedreporting
Activesurveillance–Sentinelsites,drugeventmonitoringandregistries
Comparativeobservationalstudies– Crosssectionalstudy,casecontrolstudyandcohort study
Targetedclinicalinvestigations
EffectivecommunicationinPharmacovigilance
CommunicationinDrugSafetyCrisismanagement
CommunicatingwithRegulatoryAgencies,BusinessPartners,Healthcarefacilities&Me dia
165
Preclinicalphase
Clinicalphase
Postapprovalphase(PMS)
OrganizationandobjectivesofICH
Expeditedreporting
Individualcasesafetyreports
Periodicsafetyupdatereports
Postapprovalexpeditedreporting
Pharmacovigilanceplanning
Goodclinicalpracticeinpharmacovigilancestudies
GeneticsrelatedADRwithexamplefocusingPKparameters.
Paediatrics
Pregnancyandlactation
Geriatrics
CIOMSWorkingGroups
CIOMSForm
D&CActandScheduleY
DifferencesinIndianandglobalpharmacovigilancerequirements
TextbookofPharmacovigilance:SKGupta,JaypeeBrothers,Medical Publishers.
PracticalDrugSafetyfromAtoZByBartonCobert,PierreBiron,JonesandBartlettPubli shers.
Mann'sPharmacovigilance:ElizabethB.Andrews,Nicholas,WileyPublishers.
Stephens'DetectionofNewAdverseDrug Reactions:JohnTalbot,PatrickWalle,WileyPublishers.
AnIntroductiontoPharmacovigilance:PatrickWaller,WileyPublishers.
Cobert'sManualofDrugSafetyandPharmacovigilance:BartonCobert,Jones&Bartlett Publishers.
TextbookofPharmacoepidemiologeditedbyBrianL.Strom,StephenEKimmel,SeanH ennessy,WileyPublishers.
ATextbookofClinicalPharmacyPractice- EssentialConceptsandSkills:G.Parthasarathi,Karin NyfortHansen,MilapC.Nahata
NationalFormularyofIndia
TextBookofMedicinebyYashpal Munjal
TextbookofPharmacovigilance:conceptandpracticebyGPMohantaandPKManna
http://www.whoumc.org/DynPage.aspx?id=105825&mn1=7347&mn2=7259&mn
3=7297
knowWHO guidelines forqualitycontrol ofherbal drugs
knowQualityassurance in herbaldrugindustry
knowtheregulatoryapprovalprocessandtheirregistrationinIndianandintern ationalmarkets
appreciateEUandICH guidelinesforqualitycontrolofherbaldrugs
Basictestsfordrugs–Pharmaceuticalsubstances,Medicinalplantsmaterialsanddosageforms WHO guidelines for quality control of herbal drugs.Evaluationofcommercialcrudedrugsintended
foruse
WHOGuidelinesoncurrentgoodmanufacturingPractices(cGMP)forHerbalMedicinesWHO Guidelines onGACPforMedicinal Plants.
EU andICHguidelinesfor qualitycontrol ofherbal drugs. ResearchGuidelinesforEvaluatingtheSafetyand EfficacyofHerbal Medicines
Stabilitytestingofherbalmedicines.Applicationofvariouschromatographictechniquesinstand ardizationof herbal products.
PreparationofdocumentsfornewdrugapplicationandexportregistrationGMP requirementsandDrugs&CosmeticsAct provisions.
Regulatoryrequirements forherbalmedicines. WHOguidelinesonsafetymonitoringofherbalmedicinesinpharmacovigilancesystemsComparisonofv arious HerbalPharmacopoeias.
Roleofchemical andbiologicalmarkersinstandardizationofherbalproducts
PharmacognosybyTreaseandEvans
PharmacognosybyKokate,PurohitandGokhale
Rangari,V.D.,Text bookofPharmacognosyandPhytochemistryVol.I,CarrierPub.,2006.
Aggrawal,S.S.,HerbalDrugTechnology.UniversitiesPress,2002.
EMEA. Guidelines on Quality of Herbal Medicinal Products/Traditional MedicinalProducts,
Mukherjee, P.W. Quality Control of Herbal Drugs: An Approach to Evaluation ofBotanicals.BusinessHorizonsPublishers,NewDelhi,India,2002.
Shinde M.V., Dhalwal K., Potdar K., Mahadik K. Application of quality controlprinciplestoherbaldrugs.InternationalJournalofPhytomedicine1(2009);p.4- 8.
WHO. Quality Control Methods for Medicinal Plant Materials, World HealthOrganization,Geneva,1998.WHO.GuidelinesfortheAppropriateUseofHerba lMedicines. WHO Regional Publications, Western Pacific Series No 3, WHORegional officefortheWesternPacific,Manila,1998.
WHO. TheInternationalPharmacopeia,Vol. 2:QualitySpecifications, 3rdedn.WorldHealthOrganization,Geneva,1981.
WHO. Quality Control Methods for Medicinal Plant Materials. World HealthOrganization,Geneva, 1999.
WHO. WHO Global Atlas of Traditional, Complementary and AlternativeMedicine. 2 vol. set. Vol. 1 contains text and Vol. 2, maps. World HealthOrganization,Geneva, 2005.
WHO.GuidelinesonGoodAgriculturalandCollectionPractices(GACP)forMedi cinalPlants.WorldHealthOrganization,Geneva,2004.
Design anddiscoveryofleadmolecules
The role ofdrugdesignin drugdiscoveryprocess
TheconceptofQSAR anddocking
Variousstrategiestodevelopnewdruglikemolecules.
Thedesign ofnewdrugmolecules usingmolecularmodelingsoftware
Rationalapproachestoleaddiscovery basedontraditionalmedicine,Random
screening, Non-random screening, serendipitous drug discovery,leaddiscoverybasedondrugmetabolism,leaddiscoverybasedoncli nicalobservation.
determination ofphysicochemical parameters such as Partitioncoefficient,
Hammet’ssubstituent constant and Tafts steric constant.Hanschanalysis,FreeWilsonanalysis,3D- QSARapproacheslikeCOMFAandCOMSIA.
Moleculardocking:Rigiddocking,flexibledocking,manualdocking,Docking based screening.Denovo drugdesign.
RobertGCK, ed.,“DrugAction at theMolecularLevel”UniversityPrak PressBaltimore.
MartinYC.“QuantitativeDrugDesign”Dekker,NewYork.
DelgadoJN,RemersWAeds“Wilson&Gisvolds’sTextBookofOrganicMedicinal&P harmaceuticalChemistry”Lippincott,NewYork.
Foye WO“Principles ofMedicinalchemistry‘Lea&Febiger.
KorolkovasA,BurckhalterJH.“EssentialsofMedicinalChemistry”WileyInterscience
.
Wolf ME, ed “The Basis of Medicinal Chemistry, Burger’s Medicinal Chemistry”JohnWiley&Sons,NewYork.
PatrickGraham,L.,AnIntroductiontoMedicinalChemistry,OxfordUniversityPress.
SmithHJ,WilliamsH,eds,“IntroductiontotheprinciplesofDrugDesign”WrightBosto n.
SilvermanR.B.“TheorganicChemistryofDrugDesignandDrugAction”AcademicPre ss NewYork.
Cellbiology isabranchof biology thatstudies cells –their physiologicalproperties,theirstructure,the organelles theycontain,interactionswiththeirenvironment,theirlifecycle,division,deathand cellfunction.
Thisisdonebothonamicroscopicandmolecularlevel.
Cell biologyresearchencompassesboththegreatdiversityofsingle- celledorganismslike bacteria and protozoa,aswellasthemany specializedcellsinmulti-cellularorganismssuchas humans,plants,andsponges.
Summarize cellandmolecularbiologyhistory.
Summarizecellularfunctioningandcomposition.
Describethechemicalfoundationsofcellbiology.
SummarizetheDNApropertiesofcellbiology.
Describeproteinstructureandfunction.
Describecellularmembranestructureandfunction.
Describebasicmoleculargeneticmechanisms.
SummarizetheCellCycle
CellandMolecularBiology:DefinitionstheoryandbasicsandApplications.
CellandMolecular Biology:HistoryandSummation.
Propertiesofcellsandcellmembrane.
ProkaryoticversusEukaryotic
CellularReproduction
ChemicalFoundations–anIntroductionandReactions(Types)
DNA andtheFlowofMolecularInformation
DNAFunctioning
DNAandRNA
TypesofRNA
TranscriptionandTranslation
Proteins: DefinedandAminoAcids
ProteinStructure
RegularitiesinProteinPathways
CellularProcesses
PositiveControlandsignificanceofProteinSynthesis
ScienceofGenetics
TransgenicsandGenomicAnalysis
CellCycleanalysis
MitosisandMeiosis
CellularActivitiesandCheckpoints
CellSignals:Introduction
ReceptorsforCellSignals
SignalingPathways:Overview
MisregulationofSignalingPathways
Protein-Kinases:Functioning
W.B.HugoandA.D.Russel:PharmaceuticalMicrobiology,BlackwellScientificpubl ications,OxfordLondon.
PrescottandDunn.,IndustrialMicrobiology,4thedition,CBSPublishers&Distr ibutors,Delhi.
Pelczar,ChanKreig,Microbiology,TataMcGrawHilledn.
MalcolmHarris,BalliereTindallandCox:PharmaceuticalMicrobiology.
Rose:IndustrialMicrobiology.
Probisher,Hinsdilletal:FundamentalsofMicrobiology,9thed.Japan
CooperandGunn’s:TutorialPharmacy,CBSPublisherandDistribution.
Peppler:MicrobialTechnology.
Edward:FundamentalsofMicrobiology.
N.K.Jain:PharmaceuticalMicrobiology,VallabhPrakashan,Delhi
Bergeys manual of systematic bacteriology, Williams and Wilkins- A Waverlycompany
B.R. Glick and J.J. Pasternak: Molecular Biotechnology: Principles andApplicationsofRecombinantDNA: ASMPress WashingtonD.C.
RAGoldshyet.al.,:KubyImmunology.
Classificationofcosmeticandcosmeceuticalproducts DefinitionofcosmeticsasperIndianandEUregulations,Evolutionofcosmeceuticalsfromcosm etics,cosmetics as quasiandOTC drugs
Facewash, Moisturizingcream,ColdCream,Vanishingcreamandtheiradvantagesanddisadvantages.Appl ication of these products in formulation of cosmecuticals.Antiperspants&deodorants- Actives&mechanismofaction.
Chemistry and formulation of Para-phylene diamine based hair dye.Principles of formulation and building blocks of oral care products:Toothpasteforbleedinggums,sensitiveteeth.Teethwhitening,Mouthw ash.
Sunprotection,ClassificationofSunscreens andSPF.
Skin Care:Aloe and turmericHaircare:Hennaand amla.
Oralcare:Neemandclove
PrinciplesofCosmeticEvaluation:Principlesofsebumeter,corneometer.MeasurementofTEW L,Skin Color,Hairtensilestrength,Haircombingproperties Soaps,andsyndetbars.Evolutionandskinbenfits.
Oilyand dryskin,causesleadingtodryskin, skinmoisturisation.Basic understandingoftheterms Comedogenic,dermatitis.
Cosmetic problems associated with Hair and scalp: Dandruff, Hair fall causesCosmeticproblemsassociatedwithskin:blemishes,wrinkles,acne,pricklyheatandb odyodor.
AntiperspirantsandDeodorants-Activesandmechanismofaction
Harry’sCosmeticology,Wilkinson,Moore,SeventhEdition,George Godwin.
Cosmetics– Formulations,ManufacturingandQualityControl,P.P.Sharma,4thEdition,VandanaPub lications Pvt.Ltd., Delhi.
Text bookof cosmelicologybySanju Nanda&RoopK. Khar, TataPublishers.
Uponcompletionofthecoursethestudentshallbeableto,
Appreciatetheapplications ofvarious commonlyusedlaboratoryanimals.
Appreciateanddemonstrate
thevariousscreeningmethodsusedinpreclinicalresearc
h
Appreciateanddemonstratetheimportanceofbiostatisticsandresearchmethodology
Designandexecutearesearch hypothesisindependently
Unit–I | 08Hours |
LaboratoryAnimals: Study of CPCSEA and OECD guidelines for maintenance, breedingandconductofexperimentsonlaboratoryanimals,Commonlabanimals: Descriptionandapplicationsofdifferentspeciesandstrainsofanimals. Popular transgenicandmutant animals. Techniquesforcollectionofbloodandcommonroutesofdrugadministration in laboratory animals,Techniquesof blood collectionandeuthanasia. | |
Unit–II | 10Hours |
Preclinicalscreening models
Diuretics, nootropics, anti- Parkinson’s,antiasthmatics,Preclinical screening models: for CNS activity- analgesic,antipyretic,anti- inflammatory,generalanaesthetics,sedativeandhypnotics, antipsychotic, antidepressant, antiepileptic,antiparkinsonism,alzheimer’s disease |
Unit–III Preclinical screening models: for ANS activity, sympathomimetics,sympatholytics, parasympathomimetics, parasympatholytics, skeletalmusclerelaxants,drugsactingoneye,localanaethetics | 10Hours |
Unit–IV Preclinicalscreeningmodels:forCVSactivity-antihypertensives,diuretics, antiarrhythmic, antidyslepidemic, anti aggregatory,coagulants, and anticoagulants Preclinicalscreeningmodelsforotherimportantdrugslike antiulcer,antidiabetic,anticancerand antiasthmatics. | 10Hours |
ResearchmethodologyandBio-statistics Selectionofresearchtopic,reviewofliterature,researchhypothesisandstudyde sign Pre-clinicaldataanalysisandinterpretationusingStudents‘t’test and One-wayANOVA.Graphicalrepresentationof data | 05Hours |
FundamentalsofexperimentalPharmacology-byM.N.Ghosh
HandbookofExperimentalPharmacology-S.K.Kulakarni
CPCSEAguidelinesforlaboratoryanimalfacility.
DrugdiscoveryandEvaluationbyVogelH.G.
DrugScreeningMethodsbySureshKumar GuptaandS. K. Gupta
IntroductiontobiostatisticsandresearchmethodsbyPSSSundarRaoandJRichard
understandtheadvancedinstrumentsusedanditsapplicationsindruganalysis
understandthechromatographicseparationandanalysisofdrugs.
understandthecalibrationofvariousanalyticalinstruments
knowanalysisof drugsusingvariousanalyticalinstruments.
Principles of H-NMR and C-NMR, chemical shift, factors affecting chemicalshift, coupling constant, Spin - spin coupling, relaxation, instrumentation andapplications
Crystallography, rotating crystal technique, single crystal diffraction,powderdiffraction,structural elucidationandapplications.
Electronicbalance,UV-Visiblespectrophotometer,IRspectrophotometer,
Fluorimeter,FlamePhotometer,HPLCandGC
InstrumentalMethodsofChemicalAnalysis byB.KSharma
Organic spectroscopybyY.RSharma
TextbookofPharmaceutical Analysis byKennethA.Connors
Vogel’sTextbookofQuantitativeChemicalAnalysisbyA.I.Vogel
Practical PharmaceuticalChemistrybyA.H.BeckettandJ.B.Stenlake
OrganicChemistrybyI.L.Finar
Organic spectroscopybyWilliamKemp
QuantitativeAnalysisofDrugsbyD.C.Garrett
Quantitative Analysisof Drugs in PharmaceuticalFormulationsbyP.D. Sethi
Spectrophotometric identification of OrganicCompoundsbySilverstein
Thissubjectcoversfoundationaltopicthatareimportantforunderstandingtheneedandrequirementso fdietarysupplementsamongdifferent groupsinthepopulation.
This module aims to provide an understanding of the concepts behind the theoreticalapplicationsofdietarysupplements.Bytheendofthecourse,studentsshouldbe ableto:
Understandtheneedofsupplementsbythedifferentgroupofpeopletomaintainhealthy life.
Understandtheoutcomeofdeficienciesindietarysupplements.
Appreciatethecomponentsindietarysupplementsandtheapplication.
Appreciatetheregulatoryand commercialaspectsofdietarysupplementsincludinghealthclaims.
Definitions of Functional foods, Nutraceuticals and Dietary supplements. Classificationof Nutraceuticals, Health problems and diseases that can be prevented or cured byNutraceuticals i.e. weight control, diabetes, cancer, heart disease, stress, osteoarthritis,hypertensionetc.
Public health nutrition, maternal and child nutrition, nutrition and ageing, nutritioneducationincommunity.
Source, Name of marker compounds and their chemical nature, Medicinal uses andhealthbenefitsoffollowingusedasnutraceuticals/functionalfoods:Spirulina,Soyabean, Ginseng, Garlic, Broccoli,Gingko,Flaxseeds
Phytochemicalsasnutraceuticals:Occurrenceandcharacteristicfeatures(chemicalnaturemedicinal benefits)offollowing
Carotenoids-αandβ-Carotene,Lycopene,Xanthophylls,leutin
Sulfides:Diallylsulfides,Allyltrisulfide.
Polyphenolics:Reservetrol
Flavonoids-Rutin,Naringin,Quercitin,Anthocyanidins,catechins,Flavones
Prebiotics/Probiotics.:Fructooligosaccharides,Lactobacillum
Phytoestrogens:Isoflavones,daidzein,Geebustin,lignans
Tocopherols
Proteins,vitamins, minerals,cereal, vegetablesandbeveragesasfunctionalfoods: oats,wheatbran,ricebran, sea foods, coffee,teaandthelike.
Introduction to free radicals: Free radicals, reactive oxygen species, production of freeradicalsincells,damagingreactionsoffreeradicalsonlipids,proteins,Carbohydrates,nu cleicacids.
Dietaryfibresandcomplexcarbohydrates asfunctionalfoodingredients..
FreeradicalsinDiabetesmellitus, Inflammation, Ischemicreperfusioninjury,Cancer,Atherosclerosis, Free radicals in brain metabolism and pathology, kidney damage,muscle damage. Free radicals involvement in other disorders. Free radicals theory ofageing.
Antioxidants: Endogenous antioxidants – enzymatic and nonenzymatic antioxidantdefence,Superoxidedismutase,catalase,Glutathioneperoxidase,GlutathioneV itaminC,VitaminE,α-Lipoicacid,melatonin Syntheticantioxidants:ButylatedhydroxyToluene,ButylatedhydroxyAnisole.
Functionalfoodsforchronicdiseaseprevention
Effectofprocessing,storageandinteractionsofvariousenvironmentalfactorsonthepotentialofnut raceuticals.
RegulatoryAspects;FSSAI,FDA,FPO,MPO,AGMARK.HACCPandGMPsonFoodSafety.Ad ulterationoffoods.
PharmacopoeialSpecificationsfordietarysupplementsandnutraceuticals.
DieteticsbySriLakshmi
RoleofdietaryfibresandneutraceuticalsinpreventingdiseasesbyK.TAgustiandP.Faizal:BS Punblication.
Advanced NutritionalTherapiesbyCooper.K.A., (1996).
TheFoodPharmacybyJeanCarper,Simon&Schuster,UKLtd.,(1988).
PrescriptionforNutritionalHealingbyJamesF.BalchandPhyllisA.Balch2ndEdn.,AveryPubl ishingGroup,NY(1997).
G.GibsonandC.williamsEditors 2000FunctionalfoodsWoodheadPubl.Co.London.
Goldberg,I.FunctionalFoods.1994.ChapmanandHall,New York.
Labuza,T.P.2000FunctionalFoodsandDietarySupplements:Safety,GoodManufacturing Practice(GMPs) and Shelf Life Testing inEssentials of FunctionalFoods M.K.Sachmidland T.P.Labuzaeds.AspenPress.
HandbookofNutraceuticalsandFunctionalFoods,ThirdEdition(ModernNutrition)
Shils, ME, Olson, JA, Shike, M. 1994 Modern Nutrition in Health and Disease.Eighthedition.LeaandFebiger
Introduction to pharmaceutical product development, objectives, regulations related topreformulation,formulationdevelopment,stabilityassessment,manufacturingandqual itycontroltestingofdifferent types ofdosageforms
Anadvancedstudy ofPharmaceuticalExcipientsinpharmaceuticalproductdevelopmentwithaspecialreferenceto thefollowingcategories
Solventsandsolubilizers
Cyclodextrinsandtheirapplications
Non-ionicsurfactantsandtheirapplications
Polyethyleneglycolsandsorbitols
Suspendingandemulsifyingagents
Semisolidexcipients
AnadvancedstudyofPharmaceuticalExcipientsinpharmaceuticalproductdevelopmentw ithaspecial referencetothefollowingcategories
Tabletandcapsuleexcipients
Directlycompressiblevehicles
Coatmaterials
Excipientsinparenteralandaerosolsproducts
ExcipientsforformulationofNDDS Selectionandapplicationofexcipientsinpharmaceuticalformulationswithspecificindustr ialapplications
Optimizationtechniquesinpharmaceuticalproductdevelopment.Astudy ofvariousoptimizationtechniquesforpharmaceuticalproductdevelopmentwithspecifice xamples.Optimization by factorial designs and their applications.A study of QbD and itsapplicationinpharmaceutical productdevelopment.
Selectionandqualitycontroltestingofpackagingmaterialsforpharmaceuticalproductdev elopment-regulatoryconsiderations.
=======KnowtheoperationofM.S.Excel,SPSS,RandMINITAB®, DoE(DesignofExperiment)
Knowthevariousstatisticaltechniquestosolvestatisticalproblems
Appreciatestatisticaltechniquesinsolvingtheproblems.
=a+by,Multipleregression,standarderrorofregression– PharmaceuticalExamplesProbability:Definition of probability, Binomial distribution, Normal distribution,Poisson’sdistribution,properties -problems Sample,Population,largesample,smallsample, Nullhypothesis,alternativehypothesis,sampling, essence of sampling, types of sampling, Error-I type,Error-II type, Standarderrorofmean(SEM)-Pharmaceutical examples Parametric test: t-test(Sample, Pooled or Unpaired and Paired) , ANOVA, (One wayandTwoway),Least Significancedifference
Blockingandconfoundingsystem forTwo-level factorials
Regression modeling: Hypothesis testing in Simple and Multiple regressionmodelsIntroductiontoPracticalcomponentsofIndustrialandClinicalTrialsPr oblems:StatisticalAnalysisUsingExcel,SPSS,MINITAB®,DESIGNOFEXPERIMENTS,R- OnlineStatisticalSoftware’stoIndustrialandClinical trialapproach
Factorial Design: Definition, 22, 23design. Advantage of factorial designResponseSurfacemethodology:Centralcompositedesign,Historicaldesign, OptimizationTechniques
Pharmaceuticalstatistics- Practicalandclinicalapplications,SanfordBolton,publisherMarcel DekkerInc.NewYork.
FundamentalofStatistics –HimalayaPublishingHouse-S.C.Guptha
DesignandAnalysisofExperiments–PHI LearningPrivateLimited,
R.Pannerselvam,
Design and AnalysisofExperiments– WileyStudentsEdition,DouglasandC.Montgomery
BP802TSOCIALAND PREVENTIVEPHARMACY (Theory)
The purpose of this course is to introduce to students a number of health issues and theirchallenges. This course also introduced a number of national health programmes. Therolesofthe pharmacistinthesecontextsarealso discussed.
Afterthesuccessfulcompletionofthiscourse,thestudentshallbeableto:
Acquirehighconsciousness/realizationofcurrentissuesrelatedtohealthandpharmace uticalproblemswithinthe countryandworldwide.
Have a critical wayofthinkingbasedon current healthcaredevelopment.
Evaluate alternative ways of solving problems related tohealth andpharmaceuticalissues
programme for prevention and control of deafness, Universal immunization programme,Nationalprogrammeforcontrolofblindness,Pulsepolioprogramme.
National health intervention programme for mother and child, National family welfareprogramme, National tobacco control programme, National Malaria Prevention Program,National programme for the health care for the elderly, Social health programme; role ofWHOinIndian nationalprogram
Community services in rural, urban and school health: Functions of PHC,Improvementin rural sanitation, national urban health mission, Health promotion and education inschool.
Short Textbook of Preventive and Social Medicine, Prabhakara GN, 2nd Edition,2010,ISBN: 9789380704104, JAYPEEPublications
Textbook of Preventive and Social Medicine (Mahajan and Gupta), Edited by RoyRabindra Nath, Saha Indranil, 4thEdition, 2013, ISBN: 9789350901878, JAYPEEPublications
Review of Preventive and Social Medicine (Including Biostatistics), Jain Vivek, 6thEdition,2014,ISBN: 9789351522331, JAYPEEPublications
EssentialsofCommunity Medicine—
APracticalApproach,HiremathLalitaD,HiremathDhananjayaA,2ndEdition,2012,ISBN
:9789350250440,JAYPEEPublications
ParkTextbook ofPreventiveandSocialMedicine,KPark,21stEdition,2011,ISBN- 14:9788190128285,BANARSIDASBHANOTPUBLISHERS.
CommunityPharmacyPractice,RameshAdepu,BSPpublishers, Hyderabad
ResearchinSocialandAdministrativePharmacy,Elsevier,Ireland
The pharmaceutical industry not only needs highly qualified researchers, chemists and,technicalpeople, butalsorequires skilled managers who cantake the industry forwardby managing and taking the complex decisions which are imperative for the growth of theindustry. The KnowledgeandKnow-how ofmarketing managementgroomthe peoplefortakingachallenging rolein Sales and Productmanagement.
Definition, general concepts and scope of marketing; Distinction between marketing &selling; Marketing environment; Industry and competitive analysis; Analyzing consumerbuyingbehavior; industrial buyingbehavior.
Quantitative and qualitative aspects; size and composition of the market; demographicdescriptionsandsocio- psychologicalcharacteristicsoftheconsumer;marketsegmentation&targeting.Consumerprofi le;Motivationandprescribinghabitsofthephysician;patients' choice of physicianand retailpharmacist.Analyzing the Market;Roleofmarket research.
Classification, product line and product mix decisions, product lifecycle,productportfolioanalysis;productpositioning;New productdecisions;Productbranding,packagingandlabelingdecisions,Productmanagementinp harmaceuticalindustry.
Methods,determinantsofpromotionalmix,promotionalbudget;Anoverviewofpersonalselling
,advertising,directmail,journals,sampling,retailing, medicalexhibition,publicrelations,onlinepromotionaltechniques forOTCProducts.
160
Meaning, importance, objectives, determinants of price; pricing methods and strategies,issuesinpricemanagementinpharmaceuticalindustry.AnoverviewofDPCO(DrugP riceControlOrder)andNPPA(NationalPharmaceuticalPricingAuthority).
Vertical & Horizontal Marketing; RuralMarketing; Consumerism; Industrial Marketing;GlobalMarketing.
PhilipKotlerandKevinLaneKeller:MarketingManagement,PrenticeHallofIndia,NewDel hi
Walker,BoydandLarreche:MarketingStrategy-PlanningandImplementation,TataMC GrawHill,NewDelhi.
DhruvGrewalandMichaelLevy:Marketing,TataMCGrawHill
ArunKumarandNMenakshi:MarketingManagement,VikasPublishing,India
RajanSaxena:MarketingManagement; TataMC Graw-Hill(IndiaEdition)
Ramaswamy,U.S&Nanakamari,S:MarketingManagemnt:GlobalPerspective,IndianCon text,MacmilanIndia,NewDelhi.
Shanker,Ravi:ServiceMarketing,ExcellBooks,NewDelhi
SubbaRaoChanganti,PharmaceuticalMarketinginIndia(GIFT– Excelseries)ExcelPublications.
161
Know about the processof drugdiscoveryanddevelopment
Knowtheregulatoryauthoritiesandagenciesgoverningthemanufactureandsaleofpha rmaceuticals
KnowtheregulatoryapprovalprocessandtheirregistrationinIndianandintern ationalmarkets
Stages of drug discovery, Drug development process, pre-clinical studies, non- clinicalactivities, clinical studies,Innovator andgenerics, Concept of generics, Generic drugproductdevelopment.
Approvalprocessesandtimelines involved inInvestigationalNew Drug (IND),NewDrug Application (NDA), Abbreviated New Drug Application (ANDA). Changes to anapprovedNDA/ ANDA.
Overview of regulatory authorities of India, United States, European Union,Australia,Japan,Canada(Organizationstructureand typesofapplications)
Procedure for export of pharmaceutical products, Technical documentation, Drug MasterFiles(DMF),CommonTechnicalDocument(CTD),electronicCommonTechnical
162
Document(eCTD),ASEANCommonTechnicalDocument(ACTD)research.
Developingclinicaltrialprotocols,InstitutionalReviewBoard/IndependentEthicscommittee- formationandworkingprocedures,Informedconsentprocessandprocedures,GCPobligationso fInvestigators,sponsors&Monitors,Managing andMonitoringclinical trials,Pharmacovigilance-safetymonitoringinclinical trials
Basicterminology,guidance,guidelines,regulations,LawsandActs,Orangebook,FederalReg ister,CodeofFederalRegulatory, Purplebook
DrugRegulatoryAffairsbySachinItkar,Dr.N.S.Vyawahare,Nirali Prakashan.
The Pharmaceutical Regulatory Process, Second Edition Edited by Ira R. Berry andRobertP. Martin, Drugs and the Pharmaceutical Sciences,Vol.185. Informa HealthcarePublishers.
NewDrugApprovalProcess:AcceleratingGlobalRegistrationsByRichardAGuar ino,MD,5thedition,DrugsandthePharmaceuticalSciences,Vol.190.
Guidebookfordrugregulatorysubmissions/SandyWeinberg.ByJohnWiley&Sons.I nc.
FDARegulatoryAffairs:aguideforprescriptiondrugs,medicaldevices,andbiolo gics/edited byDouglas J. Pisano,David Mantus.
GenericDrugProductDevelopment,SolidOralDosageforms,LeonShargelandIsader Kaufer,Marcel Dekkerseries,Vol.143
ClinicalTrialsandHumanResearch:APracticalGuidetoRegulatoryComplianceByFay A.RozovskyandRodneyK.Adams
PrinciplesandPracticesof ClinicalResearch, SecondEditionEditedby JohnI.GallinandFrederick P.Ognibene
Drugs:FromDiscoveryto Approval,SecondEditionByRickNg
163
At completion of this paper it is expected that students will be able to (know, do, andappreciate):
Whydrugsafetymonitoringisimportant?
Historyanddevelopmentofpharmacovigilance
Nationalandinternationalscenarioofpharmacovigilance
Dictionaries,codingandterminologiesusedinpharmacovigilance
Detectionofnewadversedrugreactionsandtheirassessment
Internationalstandardsforclassificationofdiseasesanddrugs
Adversedrugreactionreportingsystemsandcommunicationinpharmacovigilance
Methodstogeneratesafetydataduringpreclinical,clinicalandpostapprovalphasesofdrugs’ life cycle
Drugsafetyevaluationinpaediatrics,geriatrics,pregnancyandlactation
PharmacovigilanceProgramofIndia(PvPI)requirement for ADRreportinginIndia
ICHguidelinesforICSR,PSUR,expeditedreporting,pharmacovigilanceplanning
CIOMSrequirementsforADRreporting
Writingcasenarrativesofadverseeventsandtheirquality.
HistoryanddevelopmentofPharmacovigilance
ImportanceofsafetymonitoringofMedicine
WHOinternationaldrugmonitoringprogramme
PharmacovigilanceProgramofIndia(PvPI)
DefinitionsandclassificationofADRs
Detectionandreporting
MethodsinCausalityassessment
Severityandseriousnessassessment
Predictabilityandpreventabilityassessment
Managementofadversedrugreactions
164
Terminologiesofadversemedicationrelatedevents
Regulatoryterminologies
Anatomical,therapeuticandchemicalclassificationofdrugs
Internationalclassificationofdiseases
Dailydefineddoses
InternationalNonproprietaryNamesfordrugs
WHOadversereactionterminologies
MedDRAandStandardisedMedDRAqueries
WHOdrugdictionary
Eudravigilancemedicinalproductdictionary
Basicdruginformationresources
SpecialisedresourcesforADRs
Establishinginahospital
Establishment &operationofdrugsafetydepartment inindustry
ContractResearchOrganisations(CROs)
Establishinganationalprogramme
VaccinePharmacovigilance
Vaccinationfailure
Adverseeventsfollowingimmunization
Passivesurveillance–Spontaneousreportsandcaseseries
Stimulatedreporting
Activesurveillance–Sentinelsites,drugeventmonitoringandregistries
Comparativeobservationalstudies– Crosssectionalstudy,casecontrolstudyandcohort study
Targetedclinicalinvestigations
EffectivecommunicationinPharmacovigilance
CommunicationinDrugSafetyCrisismanagement
CommunicatingwithRegulatoryAgencies,BusinessPartners,Healthcarefacilities&Me dia
165
Preclinicalphase
Clinicalphase
Postapprovalphase(PMS)
OrganizationandobjectivesofICH
Expeditedreporting
Individualcasesafetyreports
Periodicsafetyupdatereports
Postapprovalexpeditedreporting
Pharmacovigilanceplanning
Goodclinicalpracticeinpharmacovigilancestudies
GeneticsrelatedADRwithexamplefocusingPKparameters.
Paediatrics
Pregnancyandlactation
Geriatrics
CIOMSWorkingGroups
CIOMSForm
D&CActandScheduleY
DifferencesinIndianandglobalpharmacovigilancerequirements
TextbookofPharmacovigilance:SKGupta,JaypeeBrothers,Medical Publishers.
PracticalDrugSafetyfromAtoZByBartonCobert,PierreBiron,JonesandBartlettPubli shers.
Mann'sPharmacovigilance:ElizabethB.Andrews,Nicholas,WileyPublishers.
Stephens'DetectionofNewAdverseDrug Reactions:JohnTalbot,PatrickWalle,WileyPublishers.
AnIntroductiontoPharmacovigilance:PatrickWaller,WileyPublishers.
Cobert'sManualofDrugSafetyandPharmacovigilance:BartonCobert,Jones&Bartlett Publishers.
TextbookofPharmacoepidemiologeditedbyBrianL.Strom,StephenEKimmel,SeanH ennessy,WileyPublishers.
ATextbookofClinicalPharmacyPractice- EssentialConceptsandSkills:G.Parthasarathi,Karin NyfortHansen,MilapC.Nahata
NationalFormularyofIndia
TextBookofMedicinebyYashpal Munjal
TextbookofPharmacovigilance:conceptandpracticebyGPMohantaandPKManna
http://www.whoumc.org/DynPage.aspx?id=105825&mn1=7347&mn2=7259&mn
3=7297
knowWHO guidelines forqualitycontrol ofherbal drugs
knowQualityassurance in herbaldrugindustry
knowtheregulatoryapprovalprocessandtheirregistrationinIndianandintern ationalmarkets
appreciateEUandICH guidelinesforqualitycontrolofherbaldrugs
Basictestsfordrugs–Pharmaceuticalsubstances,Medicinalplantsmaterialsanddosageforms WHO guidelines for quality control of herbal drugs.Evaluationofcommercialcrudedrugsintended
foruse
WHOGuidelinesoncurrentgoodmanufacturingPractices(cGMP)forHerbalMedicinesWHO Guidelines onGACPforMedicinal Plants.
EU andICHguidelinesfor qualitycontrol ofherbal drugs. ResearchGuidelinesforEvaluatingtheSafetyand EfficacyofHerbal Medicines
Stabilitytestingofherbalmedicines.Applicationofvariouschromatographictechniquesinstand ardizationof herbal products.
PreparationofdocumentsfornewdrugapplicationandexportregistrationGMP requirementsandDrugs&CosmeticsAct provisions.
Regulatoryrequirements forherbalmedicines. WHOguidelinesonsafetymonitoringofherbalmedicinesinpharmacovigilancesystemsComparisonofv arious HerbalPharmacopoeias.
Roleofchemical andbiologicalmarkersinstandardizationofherbalproducts
PharmacognosybyTreaseandEvans
PharmacognosybyKokate,PurohitandGokhale
Rangari,V.D.,Text bookofPharmacognosyandPhytochemistryVol.I,CarrierPub.,2006.
Aggrawal,S.S.,HerbalDrugTechnology.UniversitiesPress,2002.
EMEA. Guidelines on Quality of Herbal Medicinal Products/Traditional MedicinalProducts,
Mukherjee, P.W. Quality Control of Herbal Drugs: An Approach to Evaluation ofBotanicals.BusinessHorizonsPublishers,NewDelhi,India,2002.
Shinde M.V., Dhalwal K., Potdar K., Mahadik K. Application of quality controlprinciplestoherbaldrugs.InternationalJournalofPhytomedicine1(2009);p.4- 8.
WHO. Quality Control Methods for Medicinal Plant Materials, World HealthOrganization,Geneva,1998.WHO.GuidelinesfortheAppropriateUseofHerba lMedicines. WHO Regional Publications, Western Pacific Series No 3, WHORegional officefortheWesternPacific,Manila,1998.
WHO. TheInternationalPharmacopeia,Vol. 2:QualitySpecifications, 3rdedn.WorldHealthOrganization,Geneva,1981.
WHO. Quality Control Methods for Medicinal Plant Materials. World HealthOrganization,Geneva, 1999.
WHO. WHO Global Atlas of Traditional, Complementary and AlternativeMedicine. 2 vol. set. Vol. 1 contains text and Vol. 2, maps. World HealthOrganization,Geneva, 2005.
WHO.GuidelinesonGoodAgriculturalandCollectionPractices(GACP)forMedi cinalPlants.WorldHealthOrganization,Geneva,2004.
Design anddiscoveryofleadmolecules
The role ofdrugdesignin drugdiscoveryprocess
TheconceptofQSAR anddocking
Variousstrategiestodevelopnewdruglikemolecules.
Thedesign ofnewdrugmolecules usingmolecularmodelingsoftware
Rationalapproachestoleaddiscovery basedontraditionalmedicine,Random
screening, Non-random screening, serendipitous drug discovery,leaddiscoverybasedondrugmetabolism,leaddiscoverybasedoncli nicalobservation.
determination ofphysicochemical parameters such as Partitioncoefficient,
Hammet’ssubstituent constant and Tafts steric constant.Hanschanalysis,FreeWilsonanalysis,3D- QSARapproacheslikeCOMFAandCOMSIA.
Moleculardocking:Rigiddocking,flexibledocking,manualdocking,Docking based screening.Denovo drugdesign.
RobertGCK, ed.,“DrugAction at theMolecularLevel”UniversityPrak PressBaltimore.
MartinYC.“QuantitativeDrugDesign”Dekker,NewYork.
DelgadoJN,RemersWAeds“Wilson&Gisvolds’sTextBookofOrganicMedicinal&P harmaceuticalChemistry”Lippincott,NewYork.
Foye WO“Principles ofMedicinalchemistry‘Lea&Febiger.
KorolkovasA,BurckhalterJH.“EssentialsofMedicinalChemistry”WileyInterscience
.
Wolf ME, ed “The Basis of Medicinal Chemistry, Burger’s Medicinal Chemistry”JohnWiley&Sons,NewYork.
PatrickGraham,L.,AnIntroductiontoMedicinalChemistry,OxfordUniversityPress.
SmithHJ,WilliamsH,eds,“IntroductiontotheprinciplesofDrugDesign”WrightBosto n.
SilvermanR.B.“TheorganicChemistryofDrugDesignandDrugAction”AcademicPre ss NewYork.
Cellbiology isabranchof biology thatstudies cells –their physiologicalproperties,theirstructure,the organelles theycontain,interactionswiththeirenvironment,theirlifecycle,division,deathand cellfunction.
Thisisdonebothonamicroscopicandmolecularlevel.
Cell biologyresearchencompassesboththegreatdiversityofsingle- celledorganismslike bacteria and protozoa,aswellasthemany specializedcellsinmulti-cellularorganismssuchas humans,plants,andsponges.
Summarize cellandmolecularbiologyhistory.
Summarizecellularfunctioningandcomposition.
Describethechemicalfoundationsofcellbiology.
SummarizetheDNApropertiesofcellbiology.
Describeproteinstructureandfunction.
Describecellularmembranestructureandfunction.
Describebasicmoleculargeneticmechanisms.
SummarizetheCellCycle
CellandMolecularBiology:DefinitionstheoryandbasicsandApplications.
CellandMolecular Biology:HistoryandSummation.
Propertiesofcellsandcellmembrane.
ProkaryoticversusEukaryotic
CellularReproduction
ChemicalFoundations–anIntroductionandReactions(Types)
DNA andtheFlowofMolecularInformation
DNAFunctioning
DNAandRNA
TypesofRNA
TranscriptionandTranslation
Proteins: DefinedandAminoAcids
ProteinStructure
RegularitiesinProteinPathways
CellularProcesses
PositiveControlandsignificanceofProteinSynthesis
ScienceofGenetics
TransgenicsandGenomicAnalysis
CellCycleanalysis
MitosisandMeiosis
CellularActivitiesandCheckpoints
CellSignals:Introduction
ReceptorsforCellSignals
SignalingPathways:Overview
MisregulationofSignalingPathways
Protein-Kinases:Functioning
W.B.HugoandA.D.Russel:PharmaceuticalMicrobiology,BlackwellScientificpubl ications,OxfordLondon.
PrescottandDunn.,IndustrialMicrobiology,4thedition,CBSPublishers&Distr ibutors,Delhi.
Pelczar,ChanKreig,Microbiology,TataMcGrawHilledn.
MalcolmHarris,BalliereTindallandCox:PharmaceuticalMicrobiology.
Rose:IndustrialMicrobiology.
Probisher,Hinsdilletal:FundamentalsofMicrobiology,9thed.Japan
CooperandGunn’s:TutorialPharmacy,CBSPublisherandDistribution.
Peppler:MicrobialTechnology.
Edward:FundamentalsofMicrobiology.
N.K.Jain:PharmaceuticalMicrobiology,VallabhPrakashan,Delhi
Bergeys manual of systematic bacteriology, Williams and Wilkins- A Waverlycompany
B.R. Glick and J.J. Pasternak: Molecular Biotechnology: Principles andApplicationsofRecombinantDNA: ASMPress WashingtonD.C.
RAGoldshyet.al.,:KubyImmunology.
Classificationofcosmeticandcosmeceuticalproducts DefinitionofcosmeticsasperIndianandEUregulations,Evolutionofcosmeceuticalsfromcosm etics,cosmetics as quasiandOTC drugs
Facewash, Moisturizingcream,ColdCream,Vanishingcreamandtheiradvantagesanddisadvantages.Appl ication of these products in formulation of cosmecuticals.Antiperspants&deodorants- Actives&mechanismofaction.
Chemistry and formulation of Para-phylene diamine based hair dye.Principles of formulation and building blocks of oral care products:Toothpasteforbleedinggums,sensitiveteeth.Teethwhitening,Mouthw ash.
Sunprotection,ClassificationofSunscreens andSPF.
Skin Care:Aloe and turmericHaircare:Hennaand amla.
Oralcare:Neemandclove
PrinciplesofCosmeticEvaluation:Principlesofsebumeter,corneometer.MeasurementofTEW L,Skin Color,Hairtensilestrength,Haircombingproperties Soaps,andsyndetbars.Evolutionandskinbenfits.
Oilyand dryskin,causesleadingtodryskin, skinmoisturisation.Basic understandingoftheterms Comedogenic,dermatitis.
Cosmetic problems associated with Hair and scalp: Dandruff, Hair fall causesCosmeticproblemsassociatedwithskin:blemishes,wrinkles,acne,pricklyheatandb odyodor.
AntiperspirantsandDeodorants-Activesandmechanismofaction
Harry’sCosmeticology,Wilkinson,Moore,SeventhEdition,George Godwin.
Cosmetics– Formulations,ManufacturingandQualityControl,P.P.Sharma,4thEdition,VandanaPub lications Pvt.Ltd., Delhi.
Text bookof cosmelicologybySanju Nanda&RoopK. Khar, TataPublishers.
Uponcompletionofthecoursethestudentshallbeableto,
Appreciatetheapplications ofvarious commonlyusedlaboratoryanimals.
Appreciateanddemonstrate
thevariousscreeningmethodsusedinpreclinicalresearc
h
Appreciateanddemonstratetheimportanceofbiostatisticsandresearchmethodology
Designandexecutearesearch hypothesisindependently
Unit–I | 08Hours |
LaboratoryAnimals: Study of CPCSEA and OECD guidelines for maintenance, breedingandconductofexperimentsonlaboratoryanimals,Commonlabanimals: Descriptionandapplicationsofdifferentspeciesandstrainsofanimals. Popular transgenicandmutant animals. Techniquesforcollectionofbloodandcommonroutesofdrugadministration in laboratory animals,Techniquesof blood collectionandeuthanasia. | |
Unit–II | 10Hours |
Preclinicalscreening models
Diuretics, nootropics, anti- Parkinson’s,antiasthmatics,Preclinical screening models: for CNS activity- analgesic,antipyretic,anti- inflammatory,generalanaesthetics,sedativeandhypnotics, antipsychotic, antidepressant, antiepileptic,antiparkinsonism,alzheimer’s disease |
Unit–III Preclinical screening models: for ANS activity, sympathomimetics,sympatholytics, parasympathomimetics, parasympatholytics, skeletalmusclerelaxants,drugsactingoneye,localanaethetics | 10Hours |
Unit–IV Preclinicalscreeningmodels:forCVSactivity-antihypertensives,diuretics, antiarrhythmic, antidyslepidemic, anti aggregatory,coagulants, and anticoagulants Preclinicalscreeningmodelsforotherimportantdrugslike antiulcer,antidiabetic,anticancerand antiasthmatics. | 10Hours |
ResearchmethodologyandBio-statistics Selectionofresearchtopic,reviewofliterature,researchhypothesisandstudyde sign Pre-clinicaldataanalysisandinterpretationusingStudents‘t’test and One-wayANOVA.Graphicalrepresentationof data | 05Hours |
FundamentalsofexperimentalPharmacology-byM.N.Ghosh
HandbookofExperimentalPharmacology-S.K.Kulakarni
CPCSEAguidelinesforlaboratoryanimalfacility.
DrugdiscoveryandEvaluationbyVogelH.G.
DrugScreeningMethodsbySureshKumar GuptaandS. K. Gupta
IntroductiontobiostatisticsandresearchmethodsbyPSSSundarRaoandJRichard
understandtheadvancedinstrumentsusedanditsapplicationsindruganalysis
understandthechromatographicseparationandanalysisofdrugs.
understandthecalibrationofvariousanalyticalinstruments
knowanalysisof drugsusingvariousanalyticalinstruments.
Principles of H-NMR and C-NMR, chemical shift, factors affecting chemicalshift, coupling constant, Spin - spin coupling, relaxation, instrumentation andapplications
Crystallography, rotating crystal technique, single crystal diffraction,powderdiffraction,structural elucidationandapplications.
Electronicbalance,UV-Visiblespectrophotometer,IRspectrophotometer,
Fluorimeter,FlamePhotometer,HPLCandGC
InstrumentalMethodsofChemicalAnalysis byB.KSharma
Organic spectroscopybyY.RSharma
TextbookofPharmaceutical Analysis byKennethA.Connors
Vogel’sTextbookofQuantitativeChemicalAnalysisbyA.I.Vogel
Practical PharmaceuticalChemistrybyA.H.BeckettandJ.B.Stenlake
OrganicChemistrybyI.L.Finar
Organic spectroscopybyWilliamKemp
QuantitativeAnalysisofDrugsbyD.C.Garrett
Quantitative Analysisof Drugs in PharmaceuticalFormulationsbyP.D. Sethi
Spectrophotometric identification of OrganicCompoundsbySilverstein
Thissubjectcoversfoundationaltopicthatareimportantforunderstandingtheneedandrequirementso fdietarysupplementsamongdifferent groupsinthepopulation.
This module aims to provide an understanding of the concepts behind the theoreticalapplicationsofdietarysupplements.Bytheendofthecourse,studentsshouldbe ableto:
Understandtheneedofsupplementsbythedifferentgroupofpeopletomaintainhealthy life.
Understandtheoutcomeofdeficienciesindietarysupplements.
Appreciatethecomponentsindietarysupplementsandtheapplication.
Appreciatetheregulatoryand commercialaspectsofdietarysupplementsincludinghealthclaims.
Definitions of Functional foods, Nutraceuticals and Dietary supplements. Classificationof Nutraceuticals, Health problems and diseases that can be prevented or cured byNutraceuticals i.e. weight control, diabetes, cancer, heart disease, stress, osteoarthritis,hypertensionetc.
Public health nutrition, maternal and child nutrition, nutrition and ageing, nutritioneducationincommunity.
Source, Name of marker compounds and their chemical nature, Medicinal uses andhealthbenefitsoffollowingusedasnutraceuticals/functionalfoods:Spirulina,Soyabean, Ginseng, Garlic, Broccoli,Gingko,Flaxseeds
Phytochemicalsasnutraceuticals:Occurrenceandcharacteristicfeatures(chemicalnaturemedicinal benefits)offollowing
Carotenoids-αandβ-Carotene,Lycopene,Xanthophylls,leutin
Sulfides:Diallylsulfides,Allyltrisulfide.
Polyphenolics:Reservetrol
Flavonoids-Rutin,Naringin,Quercitin,Anthocyanidins,catechins,Flavones
Prebiotics/Probiotics.:Fructooligosaccharides,Lactobacillum
Phytoestrogens:Isoflavones,daidzein,Geebustin,lignans
Tocopherols
Proteins,vitamins, minerals,cereal, vegetablesandbeveragesasfunctionalfoods: oats,wheatbran,ricebran, sea foods, coffee,teaandthelike.
Introduction to free radicals: Free radicals, reactive oxygen species, production of freeradicalsincells,damagingreactionsoffreeradicalsonlipids,proteins,Carbohydrates,nu cleicacids.
Dietaryfibresandcomplexcarbohydrates asfunctionalfoodingredients..
FreeradicalsinDiabetesmellitus, Inflammation, Ischemicreperfusioninjury,Cancer,Atherosclerosis, Free radicals in brain metabolism and pathology, kidney damage,muscle damage. Free radicals involvement in other disorders. Free radicals theory ofageing.
Antioxidants: Endogenous antioxidants – enzymatic and nonenzymatic antioxidantdefence,Superoxidedismutase,catalase,Glutathioneperoxidase,GlutathioneV itaminC,VitaminE,α-Lipoicacid,melatonin Syntheticantioxidants:ButylatedhydroxyToluene,ButylatedhydroxyAnisole.
Functionalfoodsforchronicdiseaseprevention
Effectofprocessing,storageandinteractionsofvariousenvironmentalfactorsonthepotentialofnut raceuticals.
RegulatoryAspects;FSSAI,FDA,FPO,MPO,AGMARK.HACCPandGMPsonFoodSafety.Ad ulterationoffoods.
PharmacopoeialSpecificationsfordietarysupplementsandnutraceuticals.
DieteticsbySriLakshmi
RoleofdietaryfibresandneutraceuticalsinpreventingdiseasesbyK.TAgustiandP.Faizal:BS Punblication.
Advanced NutritionalTherapiesbyCooper.K.A., (1996).
TheFoodPharmacybyJeanCarper,Simon&Schuster,UKLtd.,(1988).
PrescriptionforNutritionalHealingbyJamesF.BalchandPhyllisA.Balch2ndEdn.,AveryPubl ishingGroup,NY(1997).
G.GibsonandC.williamsEditors 2000FunctionalfoodsWoodheadPubl.Co.London.
Goldberg,I.FunctionalFoods.1994.ChapmanandHall,New York.
Labuza,T.P.2000FunctionalFoodsandDietarySupplements:Safety,GoodManufacturing Practice(GMPs) and Shelf Life Testing inEssentials of FunctionalFoods M.K.Sachmidland T.P.Labuzaeds.AspenPress.
HandbookofNutraceuticalsandFunctionalFoods,ThirdEdition(ModernNutrition)
Shils, ME, Olson, JA, Shike, M. 1994 Modern Nutrition in Health and Disease.Eighthedition.LeaandFebiger
Introduction to pharmaceutical product development, objectives, regulations related topreformulation,formulationdevelopment,stabilityassessment,manufacturingandqual itycontroltestingofdifferent types ofdosageforms
Anadvancedstudy ofPharmaceuticalExcipientsinpharmaceuticalproductdevelopmentwithaspecialreferenceto thefollowingcategories
Solventsandsolubilizers
Cyclodextrinsandtheirapplications
Non-ionicsurfactantsandtheirapplications
Polyethyleneglycolsandsorbitols
Suspendingandemulsifyingagents
Semisolidexcipients
AnadvancedstudyofPharmaceuticalExcipientsinpharmaceuticalproductdevelopmentw ithaspecial referencetothefollowingcategories
Tabletandcapsuleexcipients
Directlycompressiblevehicles
Coatmaterials
Excipientsinparenteralandaerosolsproducts
ExcipientsforformulationofNDDS Selectionandapplicationofexcipientsinpharmaceuticalformulationswithspecificindustr ialapplications
Optimizationtechniquesinpharmaceuticalproductdevelopment.Astudy ofvariousoptimizationtechniquesforpharmaceuticalproductdevelopmentwithspecifice xamples.Optimization by factorial designs and their applications.A study of QbD and itsapplicationinpharmaceutical productdevelopment.
Selectionandqualitycontroltestingofpackagingmaterialsforpharmaceuticalproductdev elopment-regulatoryconsiderations.
>>>>>>> html